Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02360566
Other study ID # 8211
Secondary ID
Status Completed
Phase N/A
First received February 2, 2015
Last updated September 7, 2017
Start date January 2016
Est. completion date December 2016

Study information

Verified date September 2017
Source Lawson Health Research Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Prior research has shown that people with psychotic illnesses, like schizophrenia, who make sense of and meaningfully integrate their psychotic experiences into their life story are more likely to recover from their illness. This process of developing a coherent narrative seems especially relevant for young people who are experiencing their first episode of psychosis. There is a need for interventions that can help facilitate the formation of recovery-oriented narratives, particularly in the early stage of illness. Participatory video is a group process that involves the facilitated creation of short documentary-style videos in which individuals are supported to reflect on and tell their personal stories. Although it has been used to foster self-identity, self-empowerment and "give voice" to a variety of marginalized and stigmatized populations, its use and evaluation as a clinical intervention has been limited.

The purpose of this study is to determine whether the novel use of participatory video facilitate narrative development and promote recovery for individuals with early psychosis is an effective, feasible, and acceptable means of treating youth in the early stages of psychotic illnesses. Although the current study is hypothesis generating in nature, the investigators are expecting that participating in the Participatory Video intervention will result in improvements in narrative development, symptoms, self-perceived recovery, self-esteem, self-stigma, social functioning and hope. Additionally, the investigators expect that Participatory Video intervention will prove to be acceptable to participants and a feasible intervention for early psychotic disorders.


Description:

The purpose of this study is to determine whether a novel 12-session Participatory Video intervention, is an effective, feasible, and acceptable means of treating people in the early stages of psychotic illnesses.

We intend to randomly assign 20 patients being treated for psychotic illnesses in an early intervention program to a Participatory Video intervention group or treatment as usual group (control). Participants who are randomly assigned to the Participatory Video intervention will take part in 12 expert-facilitated group-based workshops over a period of 6 months, in which they will learn how to develop, film and produce a documentary-style video of their experiences with psychosis. At the end of the 12 workshops participants will have worked together to produce a group documentary video about their experiences with psychosis and, should they wish, individual videos about their own personal experiences with psychosis. Participants in the Participatory Video intervention group will receive the intervention in addition to any treatment they would usually receive through the early psychosis program. Those assigned to the treatment as usual group will continue to receive the standard care available to them in the early psychosis program.

Participants will be evaluated at baseline, at 6-months (immediately post-intervention) and at 9 months (3 months post-intervention) on a number measures. Participatory Video intervention acceptability will be assessed through the Client Satisfaction Questionnaire and qualitative interviews, feasibility will be assessed through recruitment, consent and completion rates, and efficacy will be assessed on measures of symptoms, functioning, subjective recovery, metacognitive capacity and narrative development.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date December 2016
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender All
Age group 16 Years to 25 Years
Eligibility Inclusion Criteria:

- Participants will be current outpatients of the Prevention and Early intervention Program for Psychoses (PEPP) at LHSC.

- PEPP only accepts patients with a first onset primary psychotic illness that have not been treated with an antipsychotic for longer than one month.

- Study participants must be within their first 3 years of being accepted into PEPP.

- Participants must be fluent in English, as determined by referring clinicians or researchers (in the case of advertisement referred participants) in order to meaningfully participate in the PV intervention and complete the assessment tools.

Exclusion Criteria:

- Potential participants that show high levels of disorganized or disruptive behaviour (as determined by a cut off score of 4 or 5 on the Positive Formal

- Thought Disorder or Bizarre Behaviour items of the Scale for the Assessment of Positive Symptoms [SAPS]) such that they will not be able to meaningfully participate in the MAC intervention will be excluded from the study.

- Participants must not be simultaneously participating in any other research projects involving active interventions at PEPP.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Participatory Video Intervention for Early Psychosis
The Participatory Video intervention consists of 12 semi-structured, 2 hour group workshops over the course of a 6-month time period. Through facilitated discussion, participants will learn how to effectively work collaboratively as a member of the video production team. Together, they will choose what story of their shared experience with psychosis they would like to tell through documentary-video and how they plan to share it. Participants will be trained to operate all equipment required to bring their vision to life. Individuals will also have the opportunity, during the Participatory Video process, to create and share their own video clips, independent of the group, allowing participants to share their own video-narrative with others (friends, family members, public) as a means of engaging in dialogue around their personal experience with psychosis.

Locations

Country Name City State
n/a

Sponsors (4)

Lead Sponsor Collaborator
Lawson Health Research Institute London Health Sciences Centre, ProjectVideo Inc., University of Western Ontario, Canada

References & Publications (16)

Bery R. (2003). Participatory video that empowers. Participatory video: Images that transform and empower, 102-121.

Cavelti M, Kvrgic S, Beck EM, Rüsch N, Vauth R. Self-stigma and its relationship with insight, demoralization, and clinical outcome among people with schizophrenia spectrum disorders. Compr Psychiatry. 2012 Jul;53(5):468-79. doi: 10.1016/j.comppsych.2011.08.001. Epub 2011 Sep 28. — View Citation

Chadwick PK. Peer-professional first-person account: schizophrenia from the inside--phenomenology and the integration of causes and meanings. Schizophr Bull. 2007 Jan;33(1):166-73. Epub 2006 Sep 14. — View Citation

France CM, Uhlin BD. Narrative as an outcome domain in psychosis. Psychol Psychother. 2006 Mar;79(Pt 1):53-67. Review. — View Citation

Greben M, Schweitzer RD, Bargenquast R. Mechanisms of change in psychotherapy for people diagnosed with schizophrenia: the role of narrative reflexivity in promoting recovery. The Australian Journal of Rehabilitation Counselling 20(1): 1-14, 2014.

Luttrell W, Restler V, Fontaine C. Youth Video-Making. Handbook of Participatory Video, 164, 2012.

Lysaker PH, Buck KD, Ringer J. The recovery of metacognitive capacity in schizophrenia across 32 months of individual psychotherapy: A case study. Psychotherapy Research 17(6): 713-720, 2007.

Lysaker PH, Ringer J, Maxwell C, McGuire A, Lecomte T. Personal narratives and recovery from schizophrenia. Schizophr Res. 2010 Aug;121(1-3):271-6. doi: 10.1016/j.schres.2010.03.003. Epub 2010 Mar 26. — View Citation

McAdams DP, McLean KC. Narrative identity. Current Directions in Psychological Science 22(3): 233-238, 2013.

Norman CD, Yip AL. eHealth promotion and social innovation with youth: using social and visual media to engage diverse communities. Stud Health Technol Inform. 2012;172:54-70. — View Citation

Roe D, Davidson L. Self and narrative in schizophrenia: time to author a new story. Med Humanit. 2005 Dec;31(2):89-94. doi: 10.1136/jmh.2005.000214. — View Citation

Roe D, Hasson-Ohayon I, Mashiach-Eizenberg M, Derhy O, Lysaker PH, Yanos PT. Narrative enhancement and cognitive therapy (NECT) effectiveness: a quasi-experimental study. J Clin Psychol. 2014 Apr;70(4):303-12. doi: 10.1002/jclp.22050. Epub 2013 Oct 2. — View Citation

Shaw J, Robertson C. (1997). Participatory video: a practical approach to using video creatively in group development work. London (ua): Routledge.

White SA. (2003). Participatory video: Images that transform and empower. Sage.

Windell D, Norman RM. A qualitative analysis of influences on recovery following a first episode of psychosis. Int J Soc Psychiatry. 2013 Aug;59(5):493-500. doi: 10.1177/0020764012443751. Epub 2012 Apr 24. — View Citation

Yang KH. (2012). Reflexivity, participation, and video. The handbook of participatory video, 100-114.

* Note: There are 16 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Scale for Assessment of Positive Symptoms (SAPS) Baseline, Change from Baseline in SAPS at 6 months, change from baseline in SAPS at 9 months
Primary Scale for Assessment of Negative Symptoms (SANS) Baseline, Change from Baseline in SANS at 6 months, change from baseline in SANS at 9 months
Primary Rosenberg Self-Esteem Schedule (RSES) Baseline, Change from Baseline in RSES at 6 months, change from baseline in RSES at 9 months
Primary Self-stigma of Mental Illness Scale (SSMIS) Baseline, Change from Baseline in SSMIS at 6 months, change from baseline in SSMIS at 9 months
Primary The Beck Hopelessness Scale (BHS) Baseline, Change from Baseline in BHS at 6 months, change from baseline in BHS at 9 months
Primary Maryland Assessment of Recovery in People with Serious Mental Illness Scale (MARS) Baseline, Change from Baseline in MARS at 6 months, change from baseline in MARS at 9 months
Primary Social Functioning Scale (SFS) Baseline, Change from Baseline in SFS at 6 months, change from baseline in SFS at 9 months
Primary Profile of Mood States (POMS) Baseline, Change from Baseline in POMS at 6 months, change from baseline in POMS at 9 months
Primary Client Satisfaction Questionnaire-8 at 6 months (only to those in the Participatory Video Intervention Group)
Primary Scale to Assess Narrative Development (STAND) at 6 months
Primary Metacognition Assessment Scale-Abbreviated (MAS-A) at 6 months
Primary Qualitative Focus Group - Participant descriptions of their experience with Participatory Video and suggestions for how to improve the Participatory Video intervention at 6 months (only for those in the Participatory Video intervention group)
Primary Individual Semi-Structured Interviews - Participant description of their individual experience with the PV intervention group and any changes they feel it may have engendered in their life at 9 months (only for those in the Participatory Video-intervention group)
Primary Recruitment Rates baseline
Primary Consent Rates baseline
Primary Completion Rates at 9 months
See also
  Status Clinical Trial Phase
Recruiting NCT05039489 - A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia N/A
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT05321602 - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder Phase 1
Completed NCT04503954 - Efficacy of Chronic Disease Self-management Program in People With Schizophrenia N/A
Completed NCT02831231 - Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium Phase 1
Completed NCT05517460 - The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center N/A
Completed NCT03652974 - Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy Phase 4
Recruiting NCT04012684 - rTMS on Mismatch Negativity of Schizophrenia N/A
Recruiting NCT04481217 - Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia N/A
Completed NCT00212784 - Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) Phase 3
Completed NCT04092686 - A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia Phase 3
Completed NCT01914393 - Pediatric Open-Label Extension Study Phase 3
Recruiting NCT03790345 - Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics Phase 2/Phase 3
Recruiting NCT05956327 - Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training N/A
Terminated NCT03209778 - Involuntary Memories Investigation in Schizophrenia N/A
Terminated NCT03261817 - A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders N/A
Completed NCT02905604 - Magnetic Stimulation of the Brain in Schizophrenia or Depression N/A
Recruiting NCT05542212 - Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia N/A
Completed NCT04411979 - Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia N/A
Terminated NCT03220438 - TMS Enhancement of Visual Plasticity in Schizophrenia N/A

External Links